These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3987447)

  • 1. [Serum copper levels in malignant lymphomas].
    Peng JF; Wu KC
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):74-6, 124. PubMed ID: 3987447
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood protein, iron and copper, and leukocyte alkaline phosphatase in lymphoma].
    Martinetto P; Neretto G; Agricola R; Pellerito R; Giovanelli E; Fassio D
    Arch Sci Med (Torino); 1980; 137(1):119-26. PubMed ID: 7458644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum zinc levels in patients with malignant lymphomas.
    Kolarić K; Roguljić A; Ivanković G; Vukas D
    Acta Med Iugosl; 1975; 29(4):331-8. PubMed ID: 1189979
    [No Abstract]   [Full Text] [Related]  

  • 7. [Total serum copper in histiocyte sarcomatosis with a systemic tendency].
    Papa G; de Laurenzi A; Amadori S
    Haematologica; 1972; 57(3):179-83. PubMed ID: 4625059
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations of plasma levels in malignant lymphoma.
    Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
    Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum iron and serum copper in patients with lymphogranulomatosis].
    Anders O; Klemm HJ; Bendel L; Konrad H
    Z Gesamte Inn Med; 1984 Apr; 39(8):169-72. PubMed ID: 6730594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum copper estimation in lymphomas.
    Rawat M; Vijayvargiya R
    Indian J Med Res; 1977 Nov; 66(5):815-9. PubMed ID: 608751
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory response in patients with malignant lymphomas.
    Bambara LM; Corrocher R; Celebrano R; Martinelli L; Chilosi C; De Sandre G
    Haematologica; 1982 Apr; 67(2):207-15. PubMed ID: 6807768
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperprolactinemia in malignant lymphomas].
    Grobe N; Rühle H; Eckelmann G
    Dtsch Med Wochenschr; 1990 Nov; 115(48):1825-7. PubMed ID: 2245764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic changes in red blood cells in malignant lymphomas.
    De Bellis R; Boulard MR; Kasdorf H; Rodriguez I; Ferrando R; Di Landro J; Ferrari M; Sanguinett CM; Tanzer J
    Br J Haematol; 1979 May; 42(1):35-9. PubMed ID: 465359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum copper studies in the lymphomas and acute leukemias.
    Hrgovcic M; Tessmer CF; Brown BW; Wilbur JR; Mumford DM; Thomas FB; Shullenberger CC; Taylor G
    Prog Clin Cancer; 1973; 5():121-53. PubMed ID: 4692464
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum ferritin concentration in malignant lymphomas.
    Sacchi S; Curci G; Piccinini L; Manenti E; Bursi R; Torelli U
    Panminerva Med; 1985; 27(1):29-31. PubMed ID: 4034230
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral lymphocyte counts and prognosis in malignant lymphomas.
    Lee YT; Say C; Hori JM
    Mo Med; 1974 Feb; 71(2):69-73. PubMed ID: 4812195
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of serum copper measurement in lymphomas and several other malignancies.
    Mortazavi SH; Bani-Hashemi A; Mozafari M; Raffi A
    Cancer; 1972 May; 29(5):1193-8. PubMed ID: 4553758
    [No Abstract]   [Full Text] [Related]  

  • 19. Interpreting serum copper levels in Hodgkin's disease.
    Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
    Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
    Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
    Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.